Advanced Prostate Cancer Drug May Help at Earlier Stage - U.S. News & World Report

New York Times

Advanced Prostate Cancer Drug May Help at Earlier Stage U.S. News & World Report Adding Zytiga (abiraterone) to conventional hormonal treatments eliminated or nearly eliminated the prostate cancer in one-third of men with this often-lethal form, according to new research to be presented at next month's annual meeting of the ... J&J drug shows promise in high-risk prostate cancerReuters Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate TumorsScience Daily (press release) Trial Supports Earlier Use of a Prostate Cancer DrugNew York Times MarketWatch (press release) -Bloomberg -American Council on Science and Health all 43 news articles »

J&J drug shows promise in high-risk prostate cancer - Chicago Tribune

The Guardian

J&J drug shows promise in high-risk prostate cancer Chicago Tribune (Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six ... Unprecedented: Abiraterone in High-Risk Prostate CancerMedscape Advanced Prostate Cancer Drug May Help at Earlier StageDoctors Lounge all 133 news articles »